These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 29731903)
1. Overexpression of MMP21 and MMP28 is associated with gastric cancer progression and poor prognosis. Zhang J; Pan Q; Yan W; Wang Y; He X; Zhao Z Oncol Lett; 2018 May; 15(5):7776-7782. PubMed ID: 29731903 [TBL] [Abstract][Full Text] [Related]
2. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. Zhang S; Li L; Lin JY; Lin H World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827 [TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 is associated with disease-free survival and overall survival in patients with gastric cancer. Chu D; Zhang Z; Li Y; Zheng J; Dong G; Wang W; Ji G Int J Cancer; 2011 Aug; 129(4):887-95. PubMed ID: 20957628 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer. Gao XH; Yang XQ; Wang BC; Liu SP; Wang FB Asian Pac J Cancer Prev; 2013; 14(9):5055-60. PubMed ID: 24175775 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of matrix metalloproteinase-21 is associated with poor overall survival of patients with colorectal cancer. Huang Y; Li W; Chu D; Zheng J; Ji G; Li M; Zhang H; Wang W; Du J; Li J J Gastrointest Surg; 2011 Jul; 15(7):1188-94. PubMed ID: 21590459 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of forkhead box M1 and urokinase-type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis. Ma J; Qi G; Xu J; Ni H; Xu W; Ru G; Zhao Z; Xu W; He X Oncol Lett; 2017 Dec; 14(6):7288-7296. PubMed ID: 29344165 [TBL] [Abstract][Full Text] [Related]
7. MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma. Yao Z; Yuan T; Wang H; Yao S; Zhao Y; Liu Y; Jin S; Chu J; Xu Y; Zhou W; Yang S; Liu Y Tumour Biol; 2017 Jun; 39(6):1010428317700411. PubMed ID: 28621235 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological correlation of keratinocyte growth factor and matrix metalloproteinase-9 expression in human gastric cancer. Zhang Q; Wang P; Shao M; Chen SW; Xu ZF; Xu F; Yang ZY; Liu BY; Gu QL; Zhang WJ; Li Y Tumori; 2015; 101(5):566-71. PubMed ID: 26350198 [TBL] [Abstract][Full Text] [Related]
9. Expression levels of matrix metalloproteinase-9 in human gastric carcinoma. Chen SZ; Yao HQ; Zhu SZ; Li QY; Guo GH; Yu J Oncol Lett; 2015 Feb; 9(2):915-919. PubMed ID: 25621068 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer. Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005 [TBL] [Abstract][Full Text] [Related]
11. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Elnemr A; Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Tochiori S; Endou Y; Sasaki T Gastric Cancer; 2003; 6(1):30-8. PubMed ID: 12673424 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer. Chu D; Zhao Z; Zhou Y; Li Y; Li J; Zheng J; Zhao Q; Wang W Ann Surg Oncol; 2012 Jan; 19(1):318-25. PubMed ID: 21455597 [TBL] [Abstract][Full Text] [Related]
13. [Relationship between bFGF mRNA and MMP-9 mRNA expression in gastric carcinoma and their clinicopathological features as well as patients survival]. Zhao ZS; Yao GY; Ru GQ; Ma J; Ruan J Zhonghua Wai Ke Za Zhi; 2005 Feb; 43(3):169-72. PubMed ID: 15842896 [TBL] [Abstract][Full Text] [Related]
14. MACC1 and HGF are associated with survival in patients with gastric cancer. Dong G; Wang M; Gu G; Li S; Sun X; Li Z; Cai H; Zhu Z Oncol Lett; 2018 Mar; 15(3):3207-3213. PubMed ID: 29435059 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer. Fujimoto D; Hirono Y; Goi T; Katayama K; Yamaguchi A Anticancer Res; 2008; 28(2A):847-54. PubMed ID: 18507028 [TBL] [Abstract][Full Text] [Related]
16. Integrin αvβ6 and matrix metalloproteinase 9 correlate with survival in gastric cancer. Lian PL; Liu Z; Yang GY; Zhao R; Zhang ZY; Chen YG; Zhuang ZN; Xu KS World J Gastroenterol; 2016 Apr; 22(14):3852-9. PubMed ID: 27076771 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-12 is associated with overall survival in Chinese patients with gastric cancer. Zheng J; Chu D; Wang D; Zhu Y; Zhang X; Ji G; Zhao H; Wu G; Du J; Zhao Q J Surg Oncol; 2013 Jun; 107(7):746-51. PubMed ID: 23280473 [TBL] [Abstract][Full Text] [Related]
18. Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas. Zhao ZS; Zhou JL; Yao GY; Ru GQ; Ma J; Ruan J World J Gastroenterol; 2005 Jun; 11(21):3227-33. PubMed ID: 15929172 [TBL] [Abstract][Full Text] [Related]
19. SPARC is associated with gastric cancer progression and poor survival of patients. Zhao ZS; Wang YY; Chu YQ; Ye ZY; Tao HQ Clin Cancer Res; 2010 Jan; 16(1):260-8. PubMed ID: 20028745 [TBL] [Abstract][Full Text] [Related]
20. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer. Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]